Hydrogels and cryogels as in vitro engineered 3D neurodegenerative models: scope and significance Authors: Ishaan Shah, Anuradha Vaidya, Yvonne Reinwald, Ruchi Mishra Tiwari Published: 2026 ABSTRACT AbstractNeurodegenerative diseases (NDs) represent a diverse set of incurable and debilitating conditions that have become increasingly prevalent in recent years. A thorough understanding of the causes and mechanisms underlying these diseases is needed in order to develop effective treatments. Model systems—in vitro as well as in vivo have helped the researchers gain insights into the disease mechanisms. However, these model systems are unable to precisely mimic the pathophysiology of NDs, making them less physiologically relevant. Therefore, to bridge this gap, 3D in vitro model systems are being developed, which are better suited to recapitulate the specific features of NDs. Unlike other reviews that address these 3D in vitro model systems in a broader sense, without considering the unique material characteristics and applications of specific scaffold types, this review focuses exclusively on biomaterial-based 3D in vitro model systems, viz. hydrogels and their technically evolved versions-cryogels. Both these classes of biomaterials possess tunable physical and chemical properties, thereby serving as advanced models for NDs. This comprehensive review provides a detailed insight into hydrogel- and cryogel-based 3D culture systems, comparing their structural characteristics, mechanical design and bio-functionality, along with their ability to mimic the complex pathological processes occurring in neurodegeneration. By critically assessing their advantages and limitations, we bring to notice their overall physiological relevance as far as understanding NDs is concerned. These 3D models upon subsequent improvisation and validation could potentially be used in various aspects of drug discovery and development, starting from drug screening to early target identification for the development of neurotherapeutics. Introduction Neurodegenerative diseases (NDs) consist of a wide range of conditions that primarily affect the cells of the nervous system. NDs are characterized by progressive deterioration of the neuronal cells, because of which the neuronal cells lose their structure and function over time and ultimately die. Such neuronal damage is uncontrolled and irreversible, impacting an individual’s mobility, coordination, cognition, memory etc. NDs affect millions of people worldwide. Moreover, as life expectancy is increasing, the likelihood of developing a ND is also rising dramatically. In the case of NDs, an individual’s care and treatment typically last for a long time, during which their quality-of-life declines substantially. This decline in the quality of life is accompanied by significant monetary expenses and emotional burden [1]. Amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD) are some of the well-known NDs. At present, no effective treatments are available for curing or slowing the progression of NDs. The majority of the treatment options are simply based on alleviating the symptoms. Furthermore, many of the recently developed drugs for NDs have failed due to substandard performance in the final stages of clinical trials [2–4]. The complexity of the nervous system and the different pathophysiology’s of NDs present a significant hurdle in the drug development process [2, 5]. Hence there is an impending need to further improve our understanding of ND pathogenesis and develop new approaches for treatment and prevention. Experimental models of NDs serve as important tools to better understand the pathophysiology of NDs and to evaluate the potential of novel therapeutic approaches. An experimental model for any disease is a biological system established under controlled laboratory conditions to provide new insights into the underlying mechanisms of the disease. An ideal ND model must be able to replicate the distinctive pathological events that occur as a result of the disease as well as reproduce the necessary morphological and functional changes at the cellular, tissue and organism levels [6]. Importantly, an ND model should possess the ability to alter the normal life processes, allowing better appropriate simulation of the neurodegenerative processes [6]. Moreover, the ND model should also be able to match the corresponding time intervals between the important events that take place as a part of the disease development, to the greatest extent possible [6]. Lastly, the functional correspondence of the model in terms of the nervous system complexity should also be considered while developing a model system for NDs [6]. Figure 1 depicts the salient features of an experimental model for studying neurodegeneration. Salient features of an experimental neurodegenerative model system (Created with BioRender.com) In order to study various kinds of diseases, different experimental models depending upon their suitability as a model system, have been developed. Some of these models include bacteria, yeast, invertebrate animals, vertebrate animals, in vitro cell culture models, etc. However, every experimental model has its own set of advantages and constraints. As a result, it is necessary to understand the relevant pathophysiology of the disease and accordingly, choose a suitable model system. Out of the various experimental models, the in vitro cell culture models and in vivo (animal) models are most commonly employed for assessing the disease phenotypes of NDs. In this review, we aim to initially cover the benefits and the subsequent drawbacks of the currently existing in vitro and in vivo models of neurodegeneration. We then continue with the significant advantages that 3D in vitro cell culture models offer in comparison to the 2D cell culture and animal models, particularly targeting hydrogels and cryogels. We provide a detailed insight into the cell sources and materials involved in designing these hydrogels and cryogels for studying NDs. In vivo animal models of neurodegenerative diseases Animal models have been extensively employed for studying the process of neurodegeneration. The physiological, anatomical and genetic similarities of animals to humans form the basis for using them as model systems to elucidate the etiological and pathological processes occurring in NDs [7]. Animal models help to mimic the molecular mechanisms of proteinopathy, taking into consideration the influence of different organs and organ systems in the body, viz. the immune system and the nervous system [6]. Moreover, animal models facilitate the monitoring of the morphological and functional changes that take place with aging which is a major risk factor in case of NDs [6]. They are also very useful for testing new drugs and for pre-clinical studies. In vivo models exist for various NDs such as AD, PD, HD, ALS etc. However, using animal models comes with its own set of limitations. Even though there is similarity between humans and animal models, there are also significant differences in terms of metabolism, structure, disease development etc. [2, 6, 8, 9]. These differences make it difficult to precisely mimic the pathophysiology of the disease. Furthermore, the existing in vivo models particularly modeling AD, PD and HD fail to recapitulate the intricacy of an intact nervous system and fully capture the human disease phenotypes [10]. In vivo models also suffer from the fact that they are unable to evaluate sporadic diseases like ALS [8, 11–13]. Additionally, several clinical trials directed towards NDs have worked in animals but failed in humans. This has led to an overall low success rate, in turn questioning the scientific validity of animal experimentation [14–18]. The usage of animal models for medical research is expensive, time-consuming and is associated with several ethical issues, further questioning the practicability of these models [19]. Thus, the development of better research models overcoming these translational gaps between humans and animals is the need of the hour. Two-dimensional (2D) in vitro models of neurodegenerative diseases The gap between the animal models and human subjects may be bridged by developing novel in vitro models which offer better physiological relevance [6, 10, 11, 19]. In vitro models help to simulate the different cellular processes occurring in NDs. Importantly, in vitro models frequently involve the usage of human cells, thereby eliminating the discrepancies arising as a result of differences in species. Another advantage of using in vitro models is reduction in the duration and costs of translation, allowing for discovery of new potential drug candidates for treating NDs [19]. Moreover, two-dimensional (2D) cell culture is relatively cheaper and allows better reproducibility and evaluation of the obtained results. The traditional 2D in vitro models represent the most basic cell culture systems wherein cells are grown on flat surfaces as a monolayer. Nevertheless, these traditional model systems are not an accurate representation to understand how cells grow and function in the human body or how they are affected by disease and injury since they do not take into consideration the cell-cell and cell-extracellular environment interactions. 2D in vitro models disregard the dynamic nature of the nervous system and thereby fail to replicate the complex microenvironment of the nervous tissues [8, 20–22]. The morphology, functions, organization, etc. of cells can also be impacted when cultured in a monolayer [8, 23]. In addition, the gene and protein expression levels may get altered as a result of monolayer culturing [8, 24–26]. Finally, in 2D cell culture, the cells have unlimited access to nutrients, growth factors, oxygen, etc., which is not the case in vivo, further contributing to the discrepancy [8, 27]. Therefore, even though the 2D in vitro models, along with the in vivo models, have helped to advance the mechanistic understanding of neurodegeneration, they are of limited use as disease models. The reason being both models are unable to precisely mimic the physiology of the nervous system, thereby proving to be less physiologically relevant. Hence, in order to overcome these limitations, focus has shifted towards developing three-dimensional (3D) in vitro model systems. 3D in vitro model systems provide the closest natural replication of NDs, thereby representing the diseased human tissue outside the body much more realistically. Three-dimensional (3D) in vitro models of neurodegenerative diseases The significant advantage of using 3D in vitro models for studying neurodegeneration is the fact that 3D models go beyond the standard practice of monolayer cell culture and include the extracellular matrix (ECM). The incorporation of the ECM allows for better recapitulation of the neural microenvironment. In addition to promoting cellular interactions, the ECM also influences the processes of cell spreading, proliferation, differentiation, etc. [28, 29]. Moreover, 3D in vitro models also facilitate the co-culturing of different cell types together, enabling complex interactions within and between the various cells as well as with the extracellular components. Maintenance of stable cellular morphology is another benefit of using 3D models [30]. 3D in vitro models of neurodegeneration can be categorized into several types, such as biomaterial-based models, organoids, spheroids, 3D bioprinted models, microfluidic systems, etc. [8, 10, 19, 28, 31]. Figure 2 provides a schematic representation of the different 3D in vitro approaches used for modeling NDs. Overview of the different types of 3D in vitro model systems for NDs (Created with BioRender.com) Biomaterial-based 3D in vitro models for neurodegenerative diseases Impairments on the nervous system, either by injury or disease, have a major impact on the health of an individual since the nervous system is responsible for controlling all the functions and activities of the internal organs and body. However, because of the intricate physiology and limited capacity for self-regeneration, restoration of the damaged nervous tissues remains a crucial challenge. The traditional methods of organ transplants or artificial implants have achieved relatively limited success as plausible therapeutic interventions. Other therapeutic alternatives involve the usage of allografts or xenografts, isolated from donor cadavers or animals, respectively. However, allogenic grafting has its own set of limitations, which mainly includes the requirement of immunosuppression or decellularization to overcome the host immune system rejection [32]. In order to overcome host immune system rejection, studies were then carried out using acellular nerve grafts. Unfortunately, since the acellular nerve grafts do not contain any viable cells, there is a delay with respect to nerve regeneration and ECM remodeling [33, 34]. Even autologous grafting, which is considered to be the gold standard for treating nerve defects, has its own drawbacks, such as low availability of the donor nerves, dimension mismatches, neuroma formation, etc. [35–37]. The emergence of tissue engineering in the field of regenerative medicine as a promising alternative to traditional treatment methods is promising for restoring the functions in damaged human tissues. The primary objective of tissue engineering is to create functional 3D substitutes to repair or restore the defects in the damaged tissues. A functional substitute aims to recover the impaired function, integrate with the surrounding tissues, and ideally lasts for the remainder of the person’s life [38]. Tissue engineering research allows the reconstruction of the damaged tissues or organs using three main components: i) Synthetic ECM analogues made from biomaterials ii) Cells, and iii) Bioactive factors [32, 38]. These three components are generally referred to as the tissue engineering triad and facilitate 3D cell culture along with tissue regeneration [38]. Particularly in case of the nervous system, tissue engineering has opened up new therapeutic options. Neural tissue engineering advocates using this triad to facilitate nervous system repair. The ECM analogues initially blend in with the surrounding host tissue and, over the period of time, can be replaced by the native cells of the host, causing complete functional recovery. Biomaterial-based 3D in vitro models offer several advantages. Firstly, the biomaterials provide the necessary mechanical support and stability required for the growth of cells. Secondly, porous biomaterial scaffolds help with cell migration as well as allow the diffusion of nutrients and growth factors. Biomaterials also play a role in the organization of the ECM. Apart from being biologically compatible, an ideal biomaterial scaffold for culturing neuronal cells should be non-toxic, biodegradable, highly porous, have appropriate mechanical properties reassembling the neuronal ECM, and have the potential of being physically or chemically modified [32]. Generally, softer materials in terms of mechanical stiffness and structure are used to reproduce the physical properties of the nervous tissue [39]. Among the recently reported biomaterials, polymers of either natural or synthetic origin have been largely used for the functional restoration of nervous tissues [40]. This is mainly because of the polymers’ structural flexibility, accompanied by their high biocompatibility, degradability, and ability for functionalization with other desired compounds. Moreover, the mechanical properties of polymers are also highly suitable for neural tissue reconstruction [32, 40]. This versatility makes polymers the ideal choice for neural applications, in comparison to other biomaterial types like metals, ceramics, etc. Each natural and synthetic polymer possesses specific chemical, mechanical, and biological properties and thus is chosen based on the required application. Natural polymers such as chitosan, gelatin, collagen, keratin, alginate are highly biocompatible and biodegradable but are weak in terms of mechanical strength [40]. On the other hand, synthetic polymers such as polyethylene glycol (PEG), polylactic acid (PLA), polyglycolic acid (PGA), 2-hydroxyethymethacrylate (HEMA) possess good mechanical strength, flexibility, and can be modified easily. However, synthetic polymers could result in toxic and immunological reactions [40]. Hence, to improve the overall efficacy of biomaterials, several researchers often use a combination of natural and synthetic polymers. In such composite materials, natural polymers contribute to the biocompatibility and non-toxicity, while synthetic polymers help with the mechanical integrity [40, 41]. For development of 3D in vitro models for neurodegeneration, the neuronal cells initially need to be cultured onto the suitable biocompatible biomaterial scaffold. Neuronal cells can range from primary cortical neurons to glial cells and even include neural stem cells or induced pluripotent stem cells (iPSCs). Importantly, certain bioactive drugs, neurotrophic factors, or anti-inflammatory molecules are often incorporated into the scaffold to support the culturing of cells [42, 43]. Once the neuronal cells have been cultured onto the scaffold, the process of neurodegeneration can be induced to mimic the pathological processes occurring in NDs. The major approaches employed to induce neurodegeneration include protein aggregation strategies, usage of chemical toxins, oxidative stress induction, excitotoxicity, etc. After inducing neurodegeneration, researchers analyze several readouts in terms of cell viability (MTT assay, live/dead staining), expression of neuronal markers (βIII-tubulin, MAP2), apoptosis markers (Caspase-3 activation), autophagy markers (LC3-II flux, p62 accumulation), TUNEL assay, to name a few [42]. Conversely, neuroregeneration studies aim to reproduce processes such as neurite outgrowth, axonal regeneration, and neuronal differentiation after the damage caused by neurodegenerative conditions. Regenerative treatments can then be applied via introduction of stem cells, growth factors, or drugs to assess the cellular recovery using different molecular and functional assays [43]. Hydrogels Biomaterial-based 3D in vitro models are, in turn, classified majorly into two types—hydrogels and cryogels, each of which is composed either of natural polymers, synthetic polymers, or a combination of the two. Hybrid materials, predominantly in the form of hydrogels, have been extensively used for neural culture [29, 41, 42, 44]. Hydrogels are generally 3D cross-linked networks of hydrophilic polymers that may swell reversibly in water and retain large amounts of water in the swollen state. This water retention capacity of hydrogels is mainly attributed to the presence of hydrophilic groups such as -COOH, -NH2, -OH, -CONH2, -CONH, which interact with the water molecules through several non-covalent and covalent forces [45–47]. The hydrophilic polymers subsequently undergo cross-linking either via physical or chemical means, resulting in the formation of an extremely porous network [45, 48, 49]. The cross-linking of the polymer chains in the hydrogel network ensures that the polymers do not dissolve in the aqueous medium. Hydrogels synthesized through cross-linking among the polymer chains via non-covalent forces such as hydrogen bonding, ionic interactions, Van der Waals forces, hydrophobic interactions, etc., in the absence of any cross-linking molecule are termed as physical hydrogels. Since non-covalent forces are mechanically weak, they are unable to resist any changes in environment, making them susceptible to potential disruption. As a result, physical hydrogels are also referred to as reversible hydrogels, owing to their reversible response when exposed to external stimuli. On the other hand, in case of chemical or permanent hydrogels, strong covalent bonding occurs between the polymer chains through different cross-linking molecules, enabling them to maintain an overall stable and solid network structure [50]. According to existing scientific literature, physically cross-linked hydrogels can be synthesized by various methods. One of the basic synthesis methods involves cooling a hot polymer solution to form a stable hydrogel. Upon cooling, the polymer forms multiple helices, which subsequently aggregate together and form the hydrogel structure [51]. Another commonly employed technique is based on cross-linking by ionic interactions. Polymers containing ionic groups can be cross-linked when multivalent counterions, i.e ions of the opposite charge are added, leading to hydrogel formation. Interestingly, for polymers containing carboxyl groups, the pH of the aqueous solution is lowered such that protonation of the carboxyl group takes place, thereby resulting in intermolecular hydrogen-bonding between the polymers [52]. Apart from these, other approaches used for synthesis of physically cross-linked hydrogels include usage of amphiphilic grafts and block polymers, hydrophobized polysaccharides, freeze-thawing etc. [51, 52]. Due to their nature of cross-linking, physical hydrogels have a relatively shorter life span and accordingly are utilized where short-term drug release is desired. Moreover, these types of hydrogels are also particularly suitable for potential usage in clinical settings since they do not involve any toxic cross-linking agent as a part of their gelation process [50]. In comparison to physical hydrogels, their chemical counterparts offer superior mechanical, chemical, and surface properties. One of the most extensively used approaches for achieving covalent cross-linking is through small cross-linking agents like formaldehyde, glutaraldehyde, diethyl squarate, diglycidyl ether, genipin, etc. However, these cross-linking molecules often prove to be toxic and have limited biocompatibility [50]. Therefore, in order to overcome this issue, polymers are now being covalently cross-linked utilizing their selective functional groups. These functional groups bring about the necessary cross-linking via complex chemical reactions like Schiff base reaction or Michael addition reaction, to name a few. This type of cross-linking is particularly advantageous because the reaction time is short and the synthesized hydrogel has limited biological reactivity. Nevertheless, these reactions do not take place in a single step but rather occur as multi-step reactions and face issues pertaining to purification. Similarly, chemical hydrogels can also be prepared in situ by targeting certain light sensitive functional groups like azides and acrylates. These light sensitive moieties, when exposed to ionizing radiation like UV light undergo free radical polymerization to form functionalized hydrogels [50]. Additionally, this mechanism of free radical polymerization can also be employed in the presence of cross-linking agents for the development of chemically cross-linked hydrogels. In this mechanism, vinyl monomers such as acrylic acid, vinyl chloride, acrylamide, styrene, etc., radically polymerize in the presence of initiators like ammonium persulphate, potassium persulphate, or benzoyl peroxide and cross-linkers, viz. N,N-methylenebisacrylamide, ethyleneglycol dimethacrylate, melamine trimethylacrylamide, and melamine triacrylamide to form cross-linked homopolymers and copolymers [51]. Cellular behavior and interactions are significantly influenced by the ECM [53, 54]. The microenvironment provided by the hydrogels in terms of their 3D architecture, high water content, soft structure, and porous nature allows them to closely mimic the ECM of living tissues, particularly the nervous tissue. Moreover, the overall porous structure of hydrogels enables the flow of nutrients and exchange of gases, as well as neuronal cell growth, proliferation, and migration [45, 48, 55]. Apart from providing mechanical support for cell growth, hydrogels also function as a carrier for delivering chemical cues, bioactive molecules, neurotrophic factors, electrical signals, thereby promoting neuronal repair and regeneration [56]. Hydrogels can be prepared using both natural and synthetic polymers. Some of the natural polymers that are used for development of such hydrogels are collagen, gelatin, alginate, chitosan, hyaluronic acid, etc., which are discussed further in detail as follows: Collagen Type 1 fibrillary collagen, the most common type of collagen known in humans, is the major building block of connective tissues and provides overall structure and support to the body [38, 40, 57]. In addition to being readily available, collagen as a biopolymer is highly biocompatible, biodegradable, versatile and is associated with low antigenicity and cytotoxic response [58, 59]. Studies have shown that hydrogels consisting of collagen have promoted adhesion and differentiation of cells [60, 61]. In a variety of animal models, collagen-based hydrogels, either singly or in combination with nerve growth factor (NGF) have repaired the nerve gaps ranging in size from 5 mm to 35 mm [40, 59, 62–64]. As far as spinal cord injuries (SCI) are concerned, collagen-based biomaterials in conjunction with neural stem cells (NSCs) have helped to enhance axon reconnection and neural outgrowth [65]. Furthermore, collagen is also combined with other biopolymers such as chitosan, naringin, or alginate. Both chitosan/collagen hybrid hydrogel nerve conduits and collagen/naringin hydrogels have been used for peripheral nerve reconstruction [66–68]. Researchers have also used collagen in combination with alginate to develop a 3D matrix for investigating the behavior and growth of cortical neurons derived from human induced pluripotent stem cells (iPSCs) [69]. Similarly, collagen-based biomaterials have been employed for stimulating the production of neurotrophic factors in human umbilical cord blood (UCB) cells [70]. Importantly, out of all the different biopolymers available, collagen is the only polymer whose use has been approved for clinical testing [71]. NeuraGen® and Neuromaix® are two such collagen-based nerve guides that have shown promising results in clinical trials [72, 73]. In a study concerning AD, collagen-based hydrogels were employed to develop an in vitro model of blood brain barrier impacted by the disease. The developed model was able to closely recapitulate several critical aspects associated with blood brain barrier in AD, including an increase in barrier permeability, deposition of β-amyloid peptides in the vascular endothelium, etc. [74]. Moreover, collagen hydrogels upon reinforcement with silk fibers have shown also promise for long-term studies pertaining to NDs [75]. Similarly, another study has revealed that collagen hydrogels supported the culturing of neurons and glial cells derived from stem cells of AD patients for over 2 years, with cell retention and stress markers remaining fairly stable [76]. Gelatin Collagen hydrolyzed with either acid or alkaline forms gelatin. Because of its swelling properties, solubility, gel forming ability, water-binding capacity, high biocompatibility and low toxicity gelatin has been viewed as a promising hydrogel candidate [77]. Studies have reported that neural cells interact with the polymer chains in the hydrogel matrix using the different amino acids present in gelatin [78]. Moreover, amongst the different amino acids, lysine and arginine potentially contribute to enhancing neural cell adhesion [79, 80]. Gelatin-based hydrogels in association with polycations have exhibited better neuronal viability in vitro as well as in vivo [81]. Gelatin is also extensively used in combination with other biopolymers in the form of electrospuns. Gelatin electrospuns with polycaprolactone (PCL) not only promotes neurite outgrowth but also support the proliferation of Schwann cells (SC) in vitro and in vivo [82–85]. Additionally, electrospuns comprising of gelatin and PLA have even facilitated differentiation of NSCs into motor neurons [86]. Alginate Alginate is a linear polysaccharide derived from brown algae. Owing to its suitable gelation properties, high biocompatibility, minimal cost, etc., alginate has gained popularity amongst the research community [87]. Several findings suggest that alginate-based hydrogels have great promise as far as peripheral nerve regeneration and SCI treatment is concerned [88–91]. Studies have shown previously that alginate-based hydrogels facilitate the regeneration of peripheral nerves over the nerve gaps in cat and rat models, resulting in expansion of the diameter of the regenerating axons [92, 93]. Moreover, a lot of research has also been done regarding the usage of alginate hydrogels for spinal care. Alginate hydrogels have the potential to serve as vehicles for the delivery of drug molecules, stem cells, neurotrophic factors, etc., to the intended lesion of the spinal cord [94–97]. Numerous studies have even highlighted the predominant use of alginate-based hydrogels for the growth and development of NSCs [98–100]. Thus, alginate hydrogels can be used as an viable option for cell-based therapies in patients with SCI, drug delivery, neural tissue regeneration, potentially leading to improved clinical outcomes [91–94, 96]. Importantly, Gilmozzi et al. in their study have reported that alginate/fibronectin scaffold-based 3D culturing and differentiation of induced pluripotent stem cells (iPSCs) derived from patients suffering from PD into dopaminergic neurons is more efficient in comparison to the traditional 2D monolayer culturing methodology [101]. Hyaluronic acid Another natural polymer widely used for neural applications is the glycosaminoglycan hyaluronic acid. Hyaluronic acid is present throughout the human body as part of the ECM and is mainly involved in lubrication. Hyaluronic acid-based hydrogels seem to offer significant potential to be used as a novel approach for treatment of NDs. Research has revealed that the mechanical properties of hyaluronic acid hydrogels impact the differentiation of neural progenitor cells (NPCs) [102]. The survival and proliferation rates of neural precursors are boosted by hyaluronic acid hydrogels, which allow them to be potentially used for treating central and peripheral nervous system-related illnesses [103–106]. Furthermore, injectable hyaluronic acid/chitosan hydrogels incorporated with NGF have promoted the adhesion and subsequent proliferation of bone marrow- derived mesenchymal stromal cells, in turn leading to peripheral nerve regeneration [107]. In a SCI rat model, hydrogels comprising of hyaluronic acid and methylcellulose modified with anti-inflammatory peptide KAFAK and brain-derived neurotrophic factor (BDNF) contributed towards the recovery of neurological functions by improving axonal regeneration to ~57.4% in comparison to ~24.5% in SCI controls, resulting in an increase in the neuronal survival [108]. Systems combining hyaluronic acid hydrogels with PLGA microspheres have also been evaluated for the potential delivery of drugs and bioactive molecules, enabling the survival and proliferation of NSCs [109]. Additionally, hyaluronic acid hydrogels blended with poly-L-lysine and Nogo-66 receptor antibody have shown to facilitate axonal growth in rats suffering from SCI [110]. Chitosan Chitosan is a major structural polysaccharide that can be obtained from crustaceans, fungi, shellfish, etc. It is a versatile polymer that shows properties such as biocompatibility, biodegradability, processability along with gel forming capabilities [40, 111]. Chitosan hydrogels have been proven to enhance cell adhesion, cell interaction, cell survival, and neurite outgrowth [112–114]. Interestingly, chitosan in combination with NGF has displayed the ability to restore the damage associated with the central and peripheral nervous system [115–118]. Moreover, studies have demonstrated that nanofibrous biomaterials developed using a combination of chitosan and polyvinyl alcohol (PVA) have helped to increase the in vitro proliferation rate of PC12 cells by ~20–25%. The addition of chitosan to the nanofibrous biomaterial helped to mitigate the issue of limited biocompatibility associated with the synthetic polymer PVA [119]. Similarly, biomaterials comprising of chitosan and PLGA have directed in vitro and in vivo neuronal differentiation, resulting in the restoration of peripheral nerves [120, 121]. Furthermore, carboxymethyl chitosan hydrogels have also shown promising results for usage as guides for supporting nerve regeneration [122]. Recently, chitosan-based 3D scaffolds have even promoted the efficient differentiation of human NSCs into cortical neurons, further signifying their promising potential for neurodegenerative disease research [123]. Thus, different studies have been carried out using chitosan-based hydrogels aimed at enhancing neural repair and regeneration by considering the tunable properties of chitosan. Polyethylene glycol (PEG) As mentioned previously in Section “Biomaterial-based 3D in vitro models for neurodegenerative diseases”, apart from natural polymers, the usage of synthetic polymers for neural tissue engineering is highly beneficial due to easy alteration of their structural properties. Hydrogels comprising of synthetic polymers such as HEMA, PEG, etc. have been extensively employed for neural applications. The synthetic polymer PEG is made up of ethylene oxide (EO) units. Apart from being biochemically inert, PEG possesses the properties of high biocompatibility, biodegradability, hydrophilicity, etc. PEG is also non-immunogenic and resists absorption of proteins [124]. PEG-based hydrogels have been reported to enhance the proliferation, differentiation, and survival of neuronal cells [125, 126]. Studies have demonstrated that the hydrogel characteristics in PEG 2D cultures influenced cellular proliferation and led to an increase in the activity of glial cells. However, no effect was observed with respect to the metabolic and apoptotic activities. On the other hand, in PEG 3D cultures, the neuronal cells exhibited a faster rate of proliferation and showed higher metabolic activity in conjunction with reduced apoptotic rates. Thus, the properties and qualities of the PEG hydrogel design appear to have a greater impact on the behavior of neuronal cells in 3D cultures in comparison to the 2D cultures [127]. Interestingly, PEG hydrogel systems have even been employed for the controlled release of different biomolecules. PLA-PEG hydrogel formulations have reportedly been used for the release of neurotrophin-3 (NT3), positively contributing to the growth of neural cells [128]. These NT3-loaded PLA-PEG hydrogels have also contributed to the regeneration of axons in spinal cord lesions in case of animal models [129]. Injectable hydrogels comprising of PEG and dimethacrylate (DMA), when incorporated with the anti-cancer drug temozolomide have helped in the prolonged release of the drug over period of time [130]. PEG hydrogels functionalized with 4-dibenzocyclooctynol (DIBO) have also significantly promoted the differentiation of encapsulated neural stem cells into fully functionalized neurons [131]. Additionally, a group of researchers even employed starPEG-heparin-based hydrogels to develop a reductionist 3D culture system for studying the regulation of human NSC plasticity and regenerative capacity in case of AD [132]. 2-Hydroxyethylmethacrylate (HEMA) 2-Hydroxyethylmethacrylate (HEMA) is another polymer commonly used in the preparation of synthetic hydrogels. HEMA forms hydrogels in water due to its hydrophilic nature along with its ability to undergo polymerization at low temperatures (between −20 °C and + 10 °C) [40]. Studies have revealed that by tweaking the formulation and surface chemistry of HEMA hydrogels, they can be tailor-made to meet the specific needs of the CNS and the PNS [133–135]. Poly(2-hydroxyethyl methacrylate) (pHEMA) hydrogels coated with laminin have facilitated the growth of astrocytes and axons while preserving the viability of the implanted induced pluripotent stem cell derived-neural progenitor cells [136]. Moreover, pHEMA-based hydrogel nerve conduits filled with the interpenetrating network of methacrylated gelatin (GelMA)-methacrylated Hyaluronic acid (HaMA) allow the seeding of SCs, along with playing a role in the attachment and subsequent proliferation of SH-SY5Y neuroblastoma cells [137]. In addition, poly(2-hydroxyethyl methacrylate-co-methyl methacrylate) (pHEMA-MMA) porous hydrogel tubes have been employed for the repair of sciatic nerves. These porous hydrogel tubes support the nerve repair by promoting the regeneration of axons, having efficiency comparable to that of autografts [138]. Usage of electroconductive polymers in hydrogels It is a well-known fact that the nervous system is a complex assemblage of neuronal cells that communicate with one another and with other cell types via conduction of electrical impulses. Thus, an ideal biomaterial for neural tissue engineering should also possess electrical properties, enabling better simulation of the neural tissue environment [139]. Therefore, nowadays, special emphasis is on developing electrically conductive polymers to suit neural applications. Electroconductive polymers possess electrons in their backbone, which allows them to conduct electricity. Apart from electrical conductivity, these polymers also possess other desirable properties, including superior stability, ability for encapsulation and subsequent release of molecules, due to which they have gained interest in neural tissue engineering. However, the suboptimal biocompatibility of these conductive polymers is an area of concern when using them as biomaterials for neural tissue engineering. Hence, to solve this problem, conductive polymers are commonly used in combination with other biocompatible polymers, thereby mitigating the issue of biocompatibility. The key electrically conductive polymers used in neural tissue engineering are polyaniline, polypyrrole, and poly (3,4-ethylenedioxythiopene) (PEDOT). Polypyrrole The monomer pyrrole upon polymerization, results in the formation of its polymer, i.e polypyrrole (PPy). In order to improve its biocompatibility, polypyrrole is frequently used in combination with biodegradable polymers like PLA, PLGA, PCL, etc. Moreover, 3D electroconductive hydrogels have been developed using polypyrrole in conjunction with natural polymers such as hyaluronic acid to aid in the recovery process following stroke and traumatic brain injury [140, 141]. In another study, hydrogels comprising of polypyrrole, alginate and poly-L-lysine played a role in the repair and restoration of nerves by promoting the neural differentiation of mouse embryonic stem cells (ESCs) [142]. In vitro and in vivo studies using polypyrrole-based hydrogels doped with tannic acid, a plant-derived polyphenol have shown promising results for stimulating tissue repair post SCI [143]. Furthermore, polypyrrole hydrogels upon incorporation with nanoporous cellulose have helped in inducing neurite outgrowth [144]. Additionally, polypyrrole-collagen-quercetin hydrogels, offering potential regeneration abilities have also been developed [145]. Polyaniline Polyaniline is considered to be one of the most adaptive conductive polymers due to its desirable characteristics of easy availability, high conductivity, suitable processivity, positive cellular response, intrinsic antibacterial effect etc. [146]. Polyaniline is mainly prepared by oxidation of aniline monomer or aniline hydrochloride in presence of ammonium peroxydisulfate under acidic conditions. This oxidation of aniline or aniline hydrochloride yields polyaniline salt (emeraldine) [146, 147]. Polyaniline hydrogels have been extensively used as substrates for the differentiation of NSCs and for promoting peripheral nerve regeneration [148, 149]. Xue J et al. have reported that injectable hydrogels made out of gelatin and polyaniline can serve as efficient carriers for the delivery of bone marrow-derived mesenchymal stem cells (BMSCs) for treating PD in mice [150]. Interestingly, hydrogels comprising of polyaniline along with chitosan have exhibited potential priming ability by inducing the neural lineage differentiation of rat adipose-derived stem cells (ADSCs) in vitro [151]. Similarly, high strength polyaniline hydrogels have also shown to support the attachment, proliferation and subsequent differentiation of NSCs into corresponding neural and glial progenitors [148]. Poly (3,4-ethylenedioxythiopene) (PEDOT) Ethylenedioxythiophene monomers combine together to form the electroconductive polymer poly (3,4-ethylenedioxythiopene) (PEDOT). Apart from demonstrating good mechanical strength, conductivity and stability, PEDOT also possesses low redox potential and optical transparency associated with its conductive state. In comparison to polypyrrole and polyaniline, relatively very few studies have been carried out using PEDOT-based hydrogels. Nonetheless, studies have reported that hybrid electroconductive hydrogels comprising of GelMA and PEDOT: Poly(styrene sulphonate) can regulate the development of NSCs required for treating Cerebral Ischemia-Reperfusion Injury [152]. Similarly, in a study carried out by Wang, L. et al., alginate-laminin-PEDOT: Poly(styrene sulphonate) hydrogel matrix supported the culturing of human iPSCs-derived cortical neurons for more than four weeks, thereby serving as a potential 3D in vitro interface for neurodegeneration studies [153]. Recently, researchers have even developed an injectable self-healing conductive hydrogel system comprising of polydopamine-coated polyurethane nanoparticles cross-linked with glycol chitosan as a potential therapeutic platform for PD. The developed hydrogel system supported the proliferation and differentiation of NSCs in vitro. Interestingly, the study also revealed that the system significantly promoted the regeneration of dopaminergic neurons, contributed to microglial polarization, and improved motor function and electrophysiological recovery in PD-induced rats [154]. Table 1 further highlights the pros and cons of the mentioned polymers (natural, synthetic, and electroconductive) as far as neuronal applications are concerned. Table 1Comparative analysis of the different polymers used for neural applicationsPolymerBiocompatibilityDegradabilityMechanical StrengthCell AdhesionElectrical ConductivityProcessabilityOther ChallengesCollagenExcellentBiodegradable, but variable ratePoor, needs reinforcementHigh, ECM-like structureNon-conductiveGood (hydrogels, scaffolds, films)Immune response risk, sterilization issues [168–172]GelatinExcellentBiodegradable, but rapid degradationPoor, weak structural supportHigh mimics ECMNon-conductiveHigh (3D printing, electrospinning)Poor thermal stability, immune response risk [40, 173–177]AlginateHighBiodegradablePoor, weak structurePoor, requires modificationNon-conductiveHigh (3D bioprinting, hydrogels)Limited ECM mimicry, immune response risk [40, 94, 178–182]Hyaluronic AcidHighBiodegradable, but rapid degradationPoor, lacks rigidityHigh, supports neural adhesionNon-conductiveModerate (hydrogels, scaffolds)Rapid degradation, limited cell-binding sites [183–188]ChitosanHighBiodegradablePoor, weak in wet conditionsModerate, requires modificationNon-conductiveGood (hydrogels, scaffolds)pH-sensitive solubility, potential inflammation [189–192]PolypyrroleModerateNon-degradablePoor, brittleModerate, can be functionalizedHighDifficult (insoluble)Processing challenges, unknown long-term effects [193–196]PolyanilineModerateNon-degradableModerate, tunablePoor, needs surface modificationHighEasy (films, nanofibers)Potential toxicity, limited clinical use [193, 197–199]Poly(3,4-ethylenedioxythiophene) (PEDOT)Moderate to HighPoorly degradable, tunableModerate, tunableModerate, needs modificationHighComplex fabricationCytotoxicity risk, long-term stability issues [200–205]Polyethylene Glycol (PEG)ExcellentNon-degradablePoor, soft and weakPoor, bio-inert without modificationNon-conductiveHigh (hydrogels, photopolymerization)Poor tissue integration, protein adsorption issues [124, 206–209] Comparative analysis of the different polymers used for neural applications Cryogels Over the years, hydrogel systems have been pivotal to the progress of Biomaterials for tissue engineering and regenerative medicine applications. However, hydrogels inherently suffer from certain limitations. First being the fact that the fragile nature of hydrogels makes their handling difficult and tedious. Secondly, the sensitivity of hydrogels to conventional sterilization processes is a cause of concern. Any biomaterial to be approved by regulatory authorities for investigation at the clinical trials stage must be able to withstand the sterilization conditions. This sterility assurance in case of biomaterials lowers the risk of infections associated with medical devices. Unfortunately, hydrogels contain water as their main constituent, which can potentially intensify the harmful effects associated with sterilizing procedures, thereby making their sterilization process complicated [155]. Another challenge with regard to usage of hydrogels is the potential release of toxic chemical moieties used in the polymerization or cross-linking processes, affecting their overall biocompatibility [156]. Moreover, in case of hydrogels, the pores are small and not interconnected which often tends to have an effect on the cell seeding, proliferation, and spreading [157, 158]. Lastly, many hydrogels are unable to offer significant support with respect to nerve regeneration as it is very difficult to match the mechanical characteristics and rates of degradation of hydrogels to the requirements of the nervous tissue [159]. Nevertheless, hydrogels still continue to have a vital role in providing new insights pertaining to cell-extracellular matrix interactions, which are critical for promoting neural tissue repair and regeneration. Therefore, the focus of the researchers has now shifted towards development of cryogels as a tool to provide better insights regarding the process of neurodegeneration. Cryogels are hydrogels in which the process of polymerization takes place in the frozen state. First, monomers are solubilized in a suitable solvent (usually water) to form a solution, which is then frozen. Under these freezing conditions, solidification of water takes place, and the formed ice crystals act as porogens for the interior pore structure of the resulting cryogel. Following crystal formation, cross-linking and polymerization of the monomers occur. After completion of polymer cross-linking, the formed solvent crystals are removed via thawing, resulting in the formation of an interconnected porous network [160]. The process of cryogel formation is depicted schematically in Fig. 3. The dense porous network makes the cryogels mechanically sturdy and robust in nature [161]. However, macroscopically, cryogels are relatively soft and possess the ability to undergo significant compression, followed by subsequent reformation upon removal of the compressive force [162]. This sponge-like property of cryogels makes them well-suited for neural applications. Moreover, the macro-porous and highly interconnected structure of cryogels even facilitates homogeneous cell seeding onto the Biomaterial, while also allowing easy diffusion of nutrients and metabolic wastes. Additionally, cryogels can also be employed as delivery systems for the efficient delivery of cells, drugs, therapeutic agents, etc., to nervous tissues [161]. Table 2 illustrates the characteristic differences between hydrogels and cryogels. Schematic representing the process of cryogel formation (Created with BioRender.com) Table 2An analysis of the properties of hydrogels compared to that of cryogelsSr. No.HydrogelsCryogels1.Polymerization process takes place at room temperature (RT)The process of polymerization occurs in the frozen state (typically at sub-zero temperatures)2.Hydrogels possess small and isolated pores; nanoporous in nature (10–200 nm)Cryogels are characterized by large and interconnected porous networks; macropores in the range of 10–500 µm3.Limited diffusion of molecules and nutrient transportEfficient diffusion of molecules and nutrient transport4.Hydrogels are relatively fragile in nature; difficult to handleCryogels are mechanically tough and sturdy; easier handling5.Hydrogels cannot retain their original shape following compression/ deformation (low elasticity and resilience)Despite significant compression/ deformation, cryogels can regain their original form (high elasticity and resilience)6.Hydrogels have a lower Young’s modulus, ranging from ~0.1–100 kPa, resulting in lower mechanical stiffnessCryogels often exhibit higher stiffness than hydrogels in mechanical tests (due to thick pore walls); Young’s modulus ranges from ~1–500 kPa7.Hydrogels require continuous hydration for keeping up their network stabilityCryogels can exist in the dehydrated state8.Sensitive to the conventional sterilization proceduresCan easily be subjected to sterilization, including moist heat An analysis of the properties of hydrogels compared to that of cryogels Similar to hydrogels, the cross-linking in case of cryogels can occur either via physical or chemical means. Cryogels prepared via physical crosslinking are seldom used as biomaterials because of their substandard physical and mechanical characteristics. As a result, chemically cross-linked cryogels, that rely particularly on covalent interactions between the polymer chains, ensure a robust 3D-network and superior mechanical strength are preferred as far as tissue regeneration is concerned [160]. The different chemical cross-linking approaches used for the development of cryogels include free radical polymerization involving ammonium persulfate (APS) and N,N,N’,N’-tetrametylethylendiamine (TEMED), glutaraldehyde-based cross-linking, divinyl sulfone (DVS)-based cross-linking, carbodiimide coupling reaction etc. Furthermore, cryogels are often prepared using two or more different materials, considering the structural and functional complexity of biological systems. The two different materials used for creating the cryogel can either be cross-linked with each other to create a network that is interconnected or can be cross-linked independent of each other to form an interpenetrating network [163, 164]. Interpenetrating networks often enable the development of more mechanically resistant cryogel systems. Like observed in hydrogels, cryogel systems are also made up of natural, synthetic and conductive polymers [165]. Table 3 illustrates the various studies involving cryogel systems used for all types of nervous system-based applications. Table 3Various nervous system-based applications of cryogelsCryogel CompositionApplicationKey FindingsGelatin-based cryogelsNeural tissue engineeringHigh biocompatibility and biodegradability; enhances cellular adhesion through RGD sequence [165]Gelatin + LamininCultivation and differentiation of stem cellsSupports differentiation of stem cells derived from human cord blood into neuronal lineages [210]Gelatin + PEGNeural tissue engineeringShows promise for neural applications [211]Gelatin + Hyaluronic AcidTissue engineeringFacilitates proliferation of bone marrow dendritic cells [212]Chitosan + GelatinDelivery of bioactive moleculesUsed to deliver alpha-ketoglutarate to Neuro-2a cells, promoting their proliferation [213]Gelatin + ChitosanPeripheral nerve regenerationSupports BMSC and Neuro-2a cell growth, contributes to nerve regeneration [214]Gelatin + Chitosan + PolypyrroleSciatic nerve repairAids in sciatic nerve regeneration in injured rats [215]Alginate + Carboxymethyl CelluloseInjectable cryogels for neural cell deliverySupports primary mouse cortical neurons, protects neuronal networks during injection [216]Methacrylated Hyaluronic Acid + Methacrylated Gelatin + PEG AcrylateNerve guidance conduitsSupports Schwann cell adhesion and proliferation, axon regeneration, and remyelination [217]Collagen + GrapheneNeuronal differentiationFacilitates differentiation of BMSCs towards neuronal lineage [218]Collagen + GrapheneSCI-associated neuroinflammationHelps in controlling inflammation in spinal cord injury models [219]PEG DiacrylateDemyelination model to mimic MS pathologyUsed as an ex vivo and in vivo model for studying MS and neuronal degeneration [220, 221]PEG + Heparin + RGDNeural precursor cell cultureSupports long-term neural precursor cell culture under static and dynamic conditions [222]PEG/HeparinProtein deliveryShows potential as an in vitro protein delivery system [223]Oligo-PEG Fumarate + PEG Diacrylate + 2-(methacryloyloxy)ethyl-trimethylammonium chlorideSpinal cord repairSupports neuronal cell proliferation (PC-12 and SH-SY5Y cells) [224]Polyaniline + Polyvinyl AlcoholElectroconductive biomaterialSupports embryonic stem cell differentiation, adhesion and proliferation of neural progenitor cells and cardiomyocytes [146]MXene + Polyvinyl AlcoholNerve repair and regenerationEnhances proliferation of PC-12 neuronal cells (by 15–44%), reduces oxidative stress and promotes neurite differentiation (by ~1.7-fold) [225]PEDOT-Polystyrene SulfonateNeuronal growthDirects neuronal cell growth using conductive macroporous cryogels [226]Carboxymethyl Cellulose + laminin, fibronectin, collagen IV and Matrigel matrix (Neurothreads)Differentiation and transplantation of mature neurons for PD’s cell therapySupports differentiation of neural progenitor cells into mature dopaminergic neurons, improves cell survival of mature neurons upon stereotactic in vivo transplantation (by ~55–60%) [227] Various nervous system-based applications of cryogels Therefore, altogether, these studies strongly suggest that cryogels serve as a viable and versatile choice of biomaterials for neural applications. The overall macroporous nature of cryogels, along with their adaptive mechanical characteristics, allows their usage not just as cell culture platforms but also as nerve guidance conduits, delivery of bioactive molecules, cell carriers, etc. Table 4 describes some of the other key studies carried out between ~2020–2025 pertaining to the usage of hydrogels and cryogels for 3D in-vitro neurodegenerative disease modeling, along with neural tissue engineering and regeneration. Table 4Recent (~2020–2025) studies using hydrogels or cryogels for neurodegenerative disease or neural tissue researchMaterialPorosityElastic ModulusCell TypeAssay ReadoutsDisease ModelReferenceMatrigel hydrogel microbeads~220 µm microbeadsSoft ECMHuman neural progenitor cellsAmyloid-β 42 (Aβ42) generation, neuronal differentiation, drug testingModel for Alzheimer’s disease[228]Adipose tissue derived-ECM (adECM) hydrogel3001–6116 nm² pore area45–393 PaNeuroectodermal stem cells (NE-4C cell line)Live/dead staining, PrestoBlue viability assay, Ki67 immunostaining, Immunocytochemistry staining, SEM analysisNeural differentiation platform/ neurodegenerative disease modeling[229]Polyacrylic acid/polyvinyl alcohol/polyethylene glycol hydrogel~91% porosity6.11 kPaPrimary neurons (hippocampal)Immunochemical staining, electrophysiology, optogenetics, neural network activityNeural circuit modeling/ Neurological disease studies[230]HET-s amyloid fibers (AF) hydrogelProtein fiber hydrogel networkSoft ECM-like matrixPrimary neurons (hippocampal)Immunochemical staining, long-term neuronal culture, network formationNeurodegenerative disease modeling[231]Conductive PVA-based cryogel electrodeMacroporous interconnected structure~32 MPa (dry state); ~ 550 kPa (hydrated state)Neural precursor cellsElectrochemical characterization, electrical stimulation assay, cell proliferation assays, immunostainingNeural regeneration/ neuromodulation model[232]Decellularized brain ECM-based NGF-releasing cryogel~90–95% porosity~0.5–3 kPaNeuronal cellsELISA, live/dead staining, Immunochemical staining,Traumatic brain injury regeneration model[233] Recent (~2020–2025) studies using hydrogels or cryogels for neurodegenerative disease or neural tissue research Despite the significant advancements in cryogel technology, certain challenges still persist that need to be acknowledged. First major limitation exists in ensuring cryogel reproducibility and consistency across different batches. Batch-to-batch variation during synthesis can potentially alter the desired characteristics of cryogels, in turn affecting their overall performance [166]. Secondly, cryogels face significant challenges in retaining their structural and mechanical properties when exposed to mechanical stress, temperature fluctuations, shifts in humidity, etc. Development of efficient and at the same time cost-effective manufacturing techniques is another key factor that needs to be taken into consideration for the widespread use of cryogels [167]. Lastly, issues pertaining to potential toxicity, immunogenicity, biodegradability, etc., of cryogels should also be addressed in order to enhance their biomedical utility. Figure 4 enlists the critical experimental controls that should be taken into consideration while preparing and evaluating cryogel systems. Critical experimental controls for cryogel preparation and evaluation (Created with BioRender.com) Figure 5 provides a detailed insight regarding the development of a hydrogel/cryogel-based 3D in vitro model system for studying neurodegeneration. Schematic illustrating the development of a hydrogel/cryogel-based 3D in vitro ND model system (Created with BioRender.com) Discussion/conclusion and future perspectives The repair and restoration of the nervous system is one of the biggest hurdles faced by modern science due to the intricate and complex anatomy of nervous tissues. Conventional medicine does not offer effective treatment for NDs, and typically the best course of action is to treat the symptoms. Nonetheless, commendable progress has been achieved, particularly in the field of cell-based therapeutics, which has greatly improved our understanding regarding the functioning of the nervous system. Experimental models of NDs are crucial to gain further insights into their complex pathology and disease phenotype. In vivo and the 2D in vitro models have proven to be extremely useful in studying cellular mechanisms and cellular interactions. However, these model systems have certain limitations as far as monitoring the ND pathogenesis is concerned, such as inherent genetic differences between animals and humans, lack of functional relevance, and structural complexity with ND-associated pathophysiology. In order to overcome these shortcomings, robust 3D in vitro models have been developed, which allow better biomimetic representation of the specific features of NDs. Our review highlights the potential of 3D in vitro models, particularly targeting biomaterial-based model systems, which marks a paradigm shift from the existing in vivo and 2D in vitro culture models used to study the process of neurodegeneration. Biomaterial-based model systems, which predominantly include hydrogels and cryogels, involve application of tissue engineering principles to help promote the cell-ECM interactions by incorporating an artificial ECM (biomaterial), thereby mimicking the tissue-like microenvironment. Hydrogels enable researchers to create a microenvironment that closely resembles the physiological features of both healthy and diseased tissues owing to their adaptable properties in terms of porosity, stiffness, and biochemical functionalization. Moreover, integrating induced pluripotent stem cells (iPSCs) derived from patients into hydrogel scaffolds can help to develop patient-specific hydrogel-based platforms, offering new avenues in personalized medicine and disease phenotype modeling. Cryogels, on the other hand, add another layer of innovation to 3D in vitro modeling of NDs. The macroporous architecture, greater permeability, and superior mechanical stability of cryogels enable them to support dynamic processes associated with chronic neurodegeneration, such as protein aggregation, neuroinflammation within a controllable and physiologically relevant microenvironment. Another feature of cryogels that sets them apart is their robustness, accompanied by their overall adaptability that permits not just live imaging but also their integration with other systems. However, several challenges still need to be addressed as far as clinical translation of these model systems is concerned. These majorly include reproducibility across studies, standardization of gel properties, long-term maintenance of neuronal phenotype, etc. Furthermore, the overall complexity of brain ECM, including vascularization and immunological interactions, cannot be fully replicated by hydrogels and cryogels, despite their ability to simulate certain features of it. Therefore, it is critically important to work together to establish standardized protocols and frameworks to enhance the overall reproducibility of these model systems, thereby ensuring that they reach their complete potential. One also needs to take into consideration the fact that in vivo and 2D in vitro model systems can’t be disregarded, as these essentially form the basis to study the pathogenesis in NDs. These conventional model systems are still widely used in research, and researchers can build upon the knowledge obtained from these experimental models to, in turn, develop more suitable 3D in vitro models that allow precise characterization of ND pathophysiology. To sum up, biomaterial-based 3D in vitro models in the form of hydrogels and cryogels potentially serve as a novel and progressive approach for expanding the frontiers of neurodegenerative research. Their ability to reproduce the architecture, mechanics, and microenvironment of the nervous system in a customizable and scalable manner makes them highly attractive for translational and therapeutic applications, including high-throughput drug screening and regenerative therapies. Acknowledgements The authors (RMT, YR) would like to thank Nottingham Trent University’s International Partnership Fund (IPF) for supporting this work. Author contributions IS contributed writing and revising the manuscript, AV contributed to revising and editing the manuscript, YR contributed to revising the manuscript, and RMT contributed to conceptualization, revising, and editing the manuscript. Compliance with ethical standards Conflict of interest The authors declare no conflict of interest. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References